Canopy Growth Corp. (TSX:WEED) Skyrockets on Another Groundbreaking Deal

Canopy Growth Corp. (TSX:WEED) (NYSE:CGC) blasts forward to gain first mover advantage in the U.S., but visibility remains weak for cannabis stocks.

| More on:

Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) was rallying almost 10% at the time of writing last Thursday, the day of the announcement of its plan to acquire leading U.S. cannabis operator, Acreage Holdings.

In an attempt to keep its first mover advantage and extend it to the U.S., Canopy Growth has made this unprecedented move to acquire “at such time as cannabis production and sale becomes federally legal in the United States.”

So it’s an acquisition that is conditional changes in the federal law.

Pretty astute.

It’s a US$3.4 billion cash and stock deal that gives Canopy the means and pathway to enter the U.S. market as soon as it is legal.

Canopy is paying $300 million today for the right to make this acquisition should federal legalization occur.

So Canopy Growth will be reporting its fourth-quarter fiscal 2019 results in June, and until then, we can expect Canopy Growth stock to trade largely based on sentiment and excitement (or nervousness) about the future of cannabis and cannabis stocks.

The situation is fluid and rapidly evolving, so it remains difficult for investors to pin down a fair value for stocks such as Canopy Growth stock.

Let’s review the last quarter to see where we’re at.

Kilograms sold increased a whopping 334% and net revenue increased 282% versus the prior quarter as the average selling price declined 12%.

Losses continued to mount as expenses increased dramatically to fund the company’s growth plans. For example, SG&A expense represented 54% of net revenue versus 43% last year.

While this is to be expected, as the company is embarking on a very aggressive growth strategy, it is nevertheless something investors should watch, as it is falling to the bottom line, reducing earnings and cash flow numbers.

Also, shares outstanding increased dramatically, because of acquisitions and compensation.

So the company’s loss from operations was $157 million, and for the first nine months of this fiscal year the company had a loss of $1.45 per share.

Shares outstanding increased significantly, and net gain on the fair value of assets increased the earnings results once again.

The stock and the industry are in their infancy and as can be expected, they are still lacking visibility, creating big risk for investors.

As an illustration of the risk and lack of visibility inherent in the stock, we can look at analysts’ earnings estimates for the next couple of years, which vary considerably.

This year’s range of EPS expectations is from as low as a loss of $2.74 to a loss of $0.64.

On the other hand, we are also seeing more partnerships and deals, which are increasingly giving the cannabis industry more opportunity and credibility.

Canopy remains the leading cannabis stock, with one of the most extensive global presences, and operations in 12 countries across five continents.

Be prepared for a wild ride, and if you’re up for it, add on weakness, and take profits to protect your money while you profit from this burgeoning business.

Fool contributor Karen Thomas has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »